Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Carcinoma and FGF19[original query] |
|---|
| Genomic Profiling Identified Prognostic Biomarkers of Definitive Chemo-Radiotherapy Response in Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): S13. Li L, Yuan S, Sun J, Yin Y, Cui J, Zhang J, Chen Y, Pang J, Yin J, Shao Y, Yu |
| Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of hepatology 2009 Jan 50 (1): 118-27. Ho Han Kiat, Pok Sharon, Streit Sylvia, Ruhe Jens E, Hart Stefan, Lim Kah Suan, Loo Hooi Linn, Aung Myat Oo, Lim Seng Gee, Ullrich Ax |
| FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. International journal of cancer. Journal international du cancer 2009 Jun 124 (12): 2880-5. Falvella Felicia S, Frullanti Elisa, Galvan Antonella, Spinola Monica, Noci Sara, De Cecco Loris, Nosotti Mario, Santambrogio Luigi, Incarbone Matteo, Alloisio Marco, Calabrò Elisa, Pastorino Ugo, Skaug Vidar, Haugen Aage, Taioli Emanuela, Dragani Tommaso |
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
| Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. Oncotarget 2016 Aug 7 (31): 49091-49098. Kaibori Masaki, Sakai Kazuko, Ishizaki Morihiko, Matsushima Hideyuki, De Velasco Marco A, Matsui Kosuke, Iida Hiroya, Kitade Hiroaki, Kwon A-Hon, Nagano Hiroaki, Wada Hiroshi, Haji Seiji, Tsukamoto Tadashi, Kanazawa Akishige, Takeda Yutaka, Takemura Shigekazu, Kubo Shoji, Nishio Kazu |
| Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients. Oncotarget 2016 Mar . Li Fan, Xia Weiliang, Wang Guan, Tan Qiang, Li Ziming, Niu Xiaomin, Ji Wenxiang, Yuan Hong, Xu Qiang, Luo Qingquan, Zhang Jie, Lu Sh |
| Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (7): 2116-2126. Harding James J, Nandakumar Subhiksha, Armenia Joshua, Khalil Danny N, Albano Melanie, Ly Michele, Shia Jinru, Hechtman Jaclyn F, Kundra Ritika, El Dika Imane, Do Richard K, Sun Yichao, Kingham T Peter, D'Angelica Michael I, Berger Michael F, Hyman David M, Jarnagin William, Klimstra David S, Janjigian Yelena Y, Solit David B, Schultz Nikolaus, Abou-Alfa Ghassan |
| Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study. Liver cancer 2019 3 8 (1): 12-23. Kang Hyo Jeong, Haq Farhan, Sung Chang Ohk, Choi Jene, Hong Seung-Mo, Eo Soo-Heang, Jeong Hui Jeong, Shin Jinho, Shim Ju Hyun, Lee Han Chu, An Jihyun, Kim Mi-Ju, Kim Kyu-Pyo, Ahn Sung-Min, Yu Euns |
| YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Cancer medicine 2019 Dec . Dai Honghai, Shao Yang W, Tong Xiaoling, Wu Xue, Pang Jiaohui, Feng Alei, Yang Z |
| Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and therapy 2020 13 12797-12809. Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe |
| Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma. Annals of translational medicine 2020 11 8 (18): 1176. Cai Xiuyu, Chen Zhenghe, Deng Meiling, Li Zhiyong, Wu Qianchao, Wei Jinwang, Dai Chun, Wang Guan, Luo Ch |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1. Cancer science 2021 12 113 (3): 1018-1027. Oshima Kotoe, Kato Ken, Ito Yoshinori, Daiko Hiroyuki, Nozaki Isao, Nakagawa Satoru, Shibuya Yuichi, Kojima Takashi, Toh Yasushi, Okada Morihito, Hironaka Shuichi, Akiyama Yuji, Komatsu Yoshito, Maejima Kazuhiro, Nakagawa Hidewaki, Onuki Ritsuko, Nagai Momoko, Kato Mamoru, Kanato Keisuke, Kuchiba Aya, Nakamura Kenichi, Kitagawa Yu |
| The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody. Frontiers in immunology 2022 7 13 930096. Liu Chenxi, Zhu Sihui, Dong Yanbing, Shao Jie, Liu Baorui, Shen J |
| Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy. Frontiers in genetics 2022 5 12 799663. Dai Honghai, Wei Yanjun, Liu Yunxia, Liu Jingwen, Yu Ruoying, Zhang Junli, Pang Jiaohui, Shao Yang, Li Qiang, Yang Z |
| Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study. American journal of cancer research 2022 1 11 (12): 6107-6118. Xue Miao, Wu Yanqin, Zhu Bowen, Zou Xinhua, Fan Wenzhe, Li Jiapi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: